LegiList
Congress, Made Clear.
Home
My LegiList
Browse
Legislators
Bills
Laws
Committees
Campaign Finance
Analytics
Weekly Briefing
Support LegiList
For past Congresses, use the Browse menu.
HR 2337
114th Congress • 2015–2017 (Ended)
To amend the Federal Food, Drug, and Cosmetic Act to authorize priority review for breakthrough devices.
Full Bill Page
Lobbying Summary
Organizations below reported lobbying activity on this bill. Expand to view filing details.
Loading filings…